Literature DB >> 2729184

Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis.

T L Merlin1, A H Tzamaloukas.   

Abstract

This case report documents successful diagnosis and therapy in a case of Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD) and reviews problems associated with CAPD peritonitis resulting from the rapidly growing mycobacteria, M.chelonae and Mycobacterium fortuitum.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2729184     DOI： 10.1093/ajcp/91.6.717

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


  6 in total

Review 1.  Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review.

Authors:  M Kunin; A Knecht; E J Holtzman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-26       Impact factor: 3.267

2.  A hospital-acquired outbreak of catheter-related nontuberculous mycobacterial infection in children on peritoneal dialysis.

Authors:  Takuji Yamada; Katsumi Ushijima; Osamu Uemura
Journal:  CEN Case Rep       Date:  2014-07-20

3.  Iatrogenic outbreak of M. chelonae skin abscesses.

Authors:  D Camargo; C Saad; F Ruiz; M E Ramirez; M Lineros; G Rodriguez; E Navarro; B Pulido; L C Orozco
Journal:  Epidemiol Infect       Date:  1996-08       Impact factor: 2.451

4.  Peritonitis from Mycobacterium wolinskyi in a chronic peritoneal dialysis patient.

Authors:  Nithin Karakala; Lisa L Steed; Michael E Ullian
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

5.  Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients.

Authors:  K Jacobson; R Garcia; H Libshitz; E Whimbey; K Rolston; D Abi-Said; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

6.  Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  C W Choi; D R Cha; Y J Kwon; W Y Cho; H J Pyo; H K Kim
Journal:  Korean J Intern Med       Date:  1993-01       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.